Roambee Acquires Modum to Capture Larger Share of Pharma Cold Chain Monitoring Market

Roambee, the Silicon Valley-headquartered global supply chain visibility provider announces its second acquisition, Modum, a European pharma last mile-focused cold chain monitoring player based in Zurich, Switzerland. This acquisition will enable Roambee to expand its cold chain visibility offering from end to end, covering primary, secondary, and the last mile delivery use-cases to strengthen its real-time cold chain monitoring solutions.

Roambee's real-time supply chain visibility platform combines firsthand sensor inputs and non-sensor data to enable the delivery of shipments and assets on time, in full, and in top condition. 300+ customers around the world, including one of the largest US-headquartered COVID-19 vaccine-makers, leverage Roambee's supply chain signals and intelligence to drive logistics automation.

Modum's 'plug & play' solutions work well in difficult logistics scenarios requiring high volume and minimal touch, such as last-mile delivery transactions. Its low unit cost of monitoring and adherence to all pharma quality compliance requirements, enables companies like Swiss Post with last-mile delivery visibility. 

Modum's CEO Simon Dössegger said, "Joining forces with Roambee was natural for Modum due to our shared mission to ensure the timely availability of effective, original products in the medical supply chain. Modum will enhance Roambee's cold chain footprint with a proven last mile visibility technology to extend the Roambee product proposition to a unique global end-to-end visibility solution. When combined with Roambee's strong multimodal shipment monitoring capabilities, we can offer granular visibility all the way from manufacturing to a patient's home at scale."

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!

  • <<
  • >>

Join the Discussion